BlackRock, Inc. 13D and 13G filings for Chinook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | BlackRock Inc. BLK | 3,954,741 6.200% | 966,810 (+32.36%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | BlackRock Inc. BLK | 2,987,931 5.600% | 2,987,931 (New Position) | Filing |